Skip to content
GenoLensGenoLens

SGCA

Chr 17q21.33

sarcoglycan alpha

Aliases:
SCARMD1, LGMD2D, adhalin, DMDA2, A2
MANE:
ENST00000262018.8

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Acute rhabdomyolysis

    BIALLELIC, autosomal or pseudoautosomal
  • Limb girdle muscular dystrophies, myofibrillar myopathies and distal myopathies

    BIALLELIC, autosomal or pseudoautosomal
  • Rhabdomyolysis and metabolic muscle disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Arthrogryposis

  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

Disease associations (Open Targets)

  • autosomal recessive limb-girdle muscular dystrophy type 2D

    0.84
  • autosomal recessive limb-girdle muscular dystrophy

    0.67
  • Abnormality of the musculature

    0.50
  • sarcoglycanopathy

    0.50
  • limb-girdle muscular dystrophy

    0.46
  • muscular dystrophy

    0.43
  • hereditary disease

    0.34
  • Elevated circulating creatine kinase concentration

    0.13
  • Alzheimer disease

    0.12
  • qualitative or quantitative defects of alpha-sarcoglycan

    0.12

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Alpha-sarcoglycan

Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.